What is oral TRT?
Oral testosterone replacement therapy (oral TRT) refers to testosterone formulations taken by mouth, as opposed to injectable testosterone (cypionate, enanthate, propionate), transdermal gels or creams, or subcutaneous pellets. The term most commonly applies today to testosterone undecanoate capsules — specifically Jatenzo and Tlando — which are FDA-approved for men with hypogonadism.
Older oral androgens, particularly methyltestosterone, are rarely prescribed today due to well-documented hepatotoxicity from 17-alpha alkylation, a chemical modification that allowed first-pass liver survival but damaged hepatic tissue at therapeutic doses. Modern oral testosterone undecanoate bypasses this problem entirely through a different absorption mechanism.
How does oral TRT work without causing liver damage?
Testosterone undecanoate is a fatty-acid ester of testosterone. When taken with food — particularly a meal containing fat — it is incorporated into lipid micelles in the intestine and absorbed via the lymphatic system (specifically the thoracic duct), bypassing the portal vein and hepatic first-pass metabolism entirely. The testosterone reaches systemic circulation without being metabolized by the liver on its initial transit.
This is the same mechanism used by testosterone undecanoate injections (Aveed), just applied to an oral capsule. The key requirement for adequate absorption is co-administration with fat-containing food. Taking oral TRT in a fasted state or with a very low-fat meal significantly reduces absorption and may result in subtherapeutic testosterone levels.
Because of the lymphatic absorption pathway, plasma testosterone levels peak a few hours after ingestion and then decline. Twice-daily dosing (morning and evening with meals) maintains more consistent levels than once-daily administration.
Modern oral testosterone absorbs through the lymphatic system, sidestepping the liver toxicity that retired the older oral androgens.
Who is oral TRT appropriate for?
Oral TRT is FDA-approved for men with hypogonadism — clinically confirmed low testosterone due to primary testicular failure or secondary (hypothalamic or pituitary) causes. Before any testosterone therapy is initiated, diagnosis requires:
- Symptomatic presentation: Classic symptoms of hypogonadism include reduced libido, fatigue, decreased muscle mass, mood changes, cognitive fog, and erectile dysfunction. Symptoms alone are not sufficient for diagnosis but are a necessary component.
- Laboratory confirmation: Low morning total testosterone on at least two separate measurements is required. Free testosterone and SHBG help contextualize total testosterone, particularly in men with borderline readings.
- Exclusion of reversible causes: Obesity, sleep apnea, hypothyroidism, pituitary tumors, and certain medications can all suppress testosterone. A thorough evaluation addresses these before initiating lifelong replacement therapy.
Oral TRT is particularly suited to men who have difficulty with injection scheduling or self-injection technique, or who prefer the convenience of a twice-daily oral dose over weekly or biweekly injections. The requirement to take each dose with a fat-containing meal is a real practical constraint that affects adherence for some patients.
Oral TRT vs injections vs gels: which is right for you?
Each delivery method has a different pharmacokinetic profile and practical trade-off:
Injectable testosterone (cypionate / enanthate)
The most commonly prescribed form in the USA. Intramuscular or subcutaneous injections are typically administered weekly or every two weeks. Testosterone levels peak shortly after injection and gradually decline before the next dose — producing a “peak and trough” pattern that some men find corresponds to noticeable energy fluctuations. Weekly dosing typically produces more stable levels than biweekly. Self-injection technique is straightforward with training.
Transdermal gels and creams
Applied daily to the skin (typically shoulders, upper arms, or inner thighs). Produces consistent, stable serum levels without injection. The primary limitations are transfer risk to partners and children if skin-to-skin contact occurs before the gel fully dries, and the need for daily application. Absorption variability across patients is a consideration; some men require higher doses to achieve therapeutic levels.
Oral TRT (testosterone undecanoate)
Twice-daily dosing, requires co-administration with food, avoids injection discomfort and transfer concerns. Produces reasonably consistent levels when taken correctly. The food requirement is the primary practical constraint, and blood pressure should be monitored — oral testosterone undecanoate carries an FDA boxed warning for cardiovascular risk, particularly related to blood pressure increase. This is monitored as part of clinical oversight.
| Delivery method | Dosing frequency | Level stability | Key constraint |
|---|---|---|---|
| Oral (testosterone undecanoate) | Twice daily | Consistent when taken with food | Must take with fat-containing meal; BP monitoring required |
| Injectable (cypionate / enanthate) | Weekly or biweekly | Peak-trough pattern; weekly more stable | Requires self-injection technique |
| Transdermal gel / cream | Daily | Consistent; absorption varies by patient | Transfer risk to partners / children; daily application |
What does clinical monitoring look like on TRT?
Responsible TRT — in any form — requires ongoing laboratory monitoring and clinical check-ins. Standard monitoring typically includes:
- Testosterone levels: Repeated at 3–6 months after initiation or dose adjustment to confirm therapeutic range. Timing of the draw relative to the dose or last application matters and should be consistent across measurements.
- Hematocrit / CBC: Testosterone stimulates erythropoiesis. Elevated hematocrit (above approximately 54%) increases blood viscosity and thromboembolic risk. Dose adjustment or therapeutic phlebotomy may be indicated.
- Estradiol: Aromatase converts testosterone to estradiol. Supraphysiological estradiol can contribute to gynecomastia, water retention, and mood changes. Some protocols include an aromatase inhibitor if estradiol rises excessively; this is a clinical judgment based on individual lab values and symptoms.
- PSA (men over 40): TRT does not cause prostate cancer, but it may accelerate growth of an existing cancer. PSA is monitored as part of standard prostate health surveillance.
- Blood pressure: Particularly relevant for oral TRT, where a blood pressure increase is a recognized risk requiring monitoring.
Can TRT affect fertility?
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis. The pituitary stops releasing LH and FSH, which are required for intratesticular testosterone production and spermatogenesis. Men who start TRT typically experience a significant decline in sperm count — in some cases to azoospermia — within weeks to months of initiation.
This suppression is generally reversible after discontinuation, but recovery of fertility is not guaranteed and can take months to years, particularly after prolonged TRT. Men who may want biological children in the future should discuss fertility preservation — including sperm banking — with their clinician before starting TRT. Alternatives like clomiphene citrate or hCG may be appropriate for men seeking testosterone support while preserving fertility.
How do you start a clinician-supervised TRT program?
Starting TRT — oral or otherwise — without a proper clinical workup is a clinical and regulatory error. Testosterone is a controlled substance in the United States (Schedule III) and requires a valid prescription from a licensed clinician who has reviewed your labs, symptoms, medical history, and contraindications.
PepScribe’s clinician-supervised hormone programs are designed for patients who want a structured, labs-required approach to testosterone therapy. A licensed clinician reviews your case, orders or reviews baseline labs, and prescribes the appropriate formulation and dose for your clinical profile. Follow-up check-ins and lab monitoring are part of the protocol, not optional additions.
If you’re evaluating whether TRT is appropriate for you, start with a clinical assessment so a licensed clinician can review your situation.
Frequently asked questions
Is oral TRT FDA-approved?
Yes. Testosterone undecanoate capsules (brand name Jatenzo and Tlando) are FDA-approved for men with low testosterone due to primary or hypogonadotropic hypogonadism. These are distinct from older methyltestosterone formulations, which carry liver toxicity concerns and are rarely used today.
How does oral testosterone work?
Modern oral testosterone undecanoate is absorbed via the lymphatic system rather than first-pass hepatic metabolism. When taken with food (particularly a high-fat meal), the drug is absorbed into intestinal lymphatics alongside dietary fat, bypassing the liver and reaching systemic circulation. This mechanism avoids the liver toxicity associated with older oral androgens.
Who is oral TRT best suited for?
Oral TRT is best suited for men who prefer not to self-inject and who reliably eat a substantial meal with each dose. It requires twice-daily dosing and consistent food intake at each administration. Men with strict dietary schedules often find it more predictable than injections; men with irregular meal patterns may have more variable absorption.
What labs are required before starting TRT?
Baseline labs for TRT typically include total testosterone (ideally drawn in the morning between 7–10 AM), free testosterone, LH, FSH, estradiol, PSA (men over 40), CBC, and a metabolic panel. Clinicians may also assess thyroid function and prolactin when evaluating for secondary hypogonadism. Repeat labs are used to titrate dose.
Can TRT affect fertility?
Yes. Exogenous testosterone suppresses the pituitary's release of LH and FSH, which are required for endogenous testosterone production and sperm generation. Men who want to preserve fertility should discuss this with their clinician before starting TRT. Alternatives like clomiphene or hCG may be appropriate for men who want symptom improvement while maintaining fertility potential.
What is the difference between TRT and anabolic steroid use?
Clinician-supervised TRT aims to restore testosterone to the normal physiological range for the individual patient. Anabolic steroid use typically involves supraphysiological doses well above normal range, with different goals and substantially different risk profiles. TRT is a medical treatment under clinical oversight, monitored via labs and regular check-ins.